Marvel CDS-AI Tools | Clinical Decision Support - DM Assistant ADA 2025

Best Treatment of type 1 diabetes

The best treatment for type 1 diabetes according to the "American Diabetes Association Releases Standards of Care in Diabetesโ€”2025" includes several key components:

1. Insulin Therapy: Insulin treatment is essential for all individuals with type 1 diabetes due to the absence of insulin production. The recommended methods include:

  • Continuous subcutaneous insulin infusion (CSII) using an insulin pump.

  • Multiple daily doses of prandial (mealtime) and basal insulin[1].


2. Insulin Analogues: Insulin analogues (e.g., rapid-acting insulins) are preferred over human insulins due to a lower risk of hypoglycemia[1].

3. Continuous Glucose Monitoring (CGM): Early use of CGM is recommended to improve glycemic outcomes and overall quality of life, while also minimizing the risk of hypoglycemia[2].

4. Automated Insulin Delivery Systems: Automated insulin delivery systems should be offered to enhance glycemic control for individuals with type 1 diabetes[3].

5. Education and Support: Education for patients on how to adjust their mealtime insulin based on carbohydrate and fat intake, as well as physical activity, is critical. This also includes strategies for managing insulin doses during different situations[4].

6. Regular Reevaluation: The insulin treatment plan should be regularly evaluated and updated, typically every 3-6 months, to ensure it meets the patients' changing needs and maximizes glycemic control[5].

7. Considering Overall Health: Comprehensive care should include monitoring for other health issues associated with diabetes, including cardiovascular risk factors, kidney disease, and eye health[6].

Patients may also consider adjunct therapies, although insulin remains the cornerstone of treatmentโ€”particularly newer options aimed at improving metabolic control should not replace insulin but may complement it under professional guidance[1][6].

This overview reflects the most current understanding from the ADA and should align with further assessments and clinical guidelines while considering individual patient circumstances including comorbidities and treatment preferences. If you have specific medications in mind or need further assistance regarding a patient's treatment plan, please let me know!

References

  1. Source: 4:2
  2. Source: 4:3
  3. Source: 4:4
  4. Source: 4:5
  5. Source: 4:6
  6. Source: 4:0